Nexus NeuroTech Ventures is a San Francisco-based neurotechnology venture studio and investment platform founded in 2023. It combines company creation, incubation, and early-stage investing in a way that is more hands-on than a standard fund. This makes it especially relevant to very early programs that need shaping as much as financing.

The platform invests across devices, software, diagnostics, services, and research tools addressing brain disorders, and it also runs an incubator for earlier-stage opportunities. Its venture-studio model means it can engage before a company is fully formed and help founders build toward investable milestones. As a newer entrant, its importance lies in being purpose-built around neurotech rather than adapting from a broader healthcare thesis.

Nexus is primarily US-focused with a broader global outlook. For neurotech founders, it is particularly relevant at pre-seed and seed stage, especially when the company is still taking shape strategically. It is best thought of as an emerging, hands-on platform for building brain disorder companies from the ground up.